Blood Spot Task Group
Updated 28 April 2026
This register lists declarations made by members in respect of interests they have that are relevant to the remit of the UK National Screening Committee’s (UK NSC’s) blood spot task group (BSTG).Â
Dr David Elliman (chair)Â
- none
Dr Felicity Boardman
- interests listed on FMCH register
Dr Jim Bonham
- interests listed on FMCH register
Gina BrondelÂ
- ²Ô´Ç²Ô±ðÌý
Christine CavanaghÂ
- works for Genomics England on the Generation StudyÂ
Dr Anupam ChakrapaniÂ
- none
Dr Llion DaviesÂ
-
Grant funding – 4 Nations research LifeArc bid in relation to rare diseases dataÂ
-
British Medical Association representative committee rolesÂ
-
Faculty of Public Health committee role and deputy faculty advisor since September 2022
Jane Fisher
- interests listed on FMCH register
Dr Sharon Hillier
- interests listed on UK NSC register
Catherine JoynsonÂ
-
member of Royal College of Physicians Committee on Ethical Issues in Medicine 2023 to 2027 (unpaid)Â
-
Cardiff University MSc Genetic and Genomic Counselling 2023-2026, self-funded research on Fatherhood and Cystic FibrosisÂ
Rachel KnowlesÂ
-
part-time employee and Clinical Principal Research Fellow at University College London (UCL)Â
-
part-time employee of the Medical Research Council (MRC)Â
-
MRC / UK Research and Innovation (UKRI) – Associate Director for Clinical Research Policy, Ethics and GovernanceÂ
-
NHS England Specialist Professional and Clinical Advisor – Clinical Advisor to the Newborn Blood Spot Screening ProgrammeÂ
-
unpaid member of the Confidentiality Advisory Group of the Health Research Authority
Dr Robin Lachmann
- interests listed on FMCH register
Prof Mariska LeeflangÂ
- ²Ô´Ç²Ô±ðÌý
Dr Helen Lewis-ParmarÂ
- ²Ô´Ç²Ô±ðÌý
Prof Anneke LucassenÂ
- interests listed on UK NSC r±ð²µ¾±²õ³Ù±ð°ùÌý
Amy Jayne McKnightÂ
- ²Ô´Ç²Ô±ðÌý
Nick MeadeÂ
- CEO of Genetic Alliance UK, which received funding in 2024-25 from: Alexion, Amicus Therapeutics, BioCryst Pharmaceuticals, Biogen, Chiesi, Ipsen, Janssen, Jazz Pharmaceuticals, Johnson & Johnson, Kyowa Kirin, Novartis, Orchard Therapeutics, Pfizer, PTC Therapeutics, Roche, Sanofi, Takeda, UCB, Vertex, Genomics England, Robert Luff Foundation Trust, LifeArc, Inthallo, D’Oyly Carte Foundation, Department of Health and Social Care, Scottish GovernmentÂ
Prof Stuart MoatÂ
-
Cardiff University honorary chair since 2018Â
-
UK MRC Grant (MR/Y008057/1):Â Co PI Lipidomic and Metabolomics for rare disease diagnosisÂ
-
Waters: newborn blood spot (NBS) second tier test and diagnostic assay development, kits/reagents supplied free of charge to undertake work, publishes dataÂ
-
Revvity: NBS assay development, kits/reagents supplied free of charge to undertake work, publishes dataÂ
-
Illumina: advising on proteomic Diagnostic assay development – potential applications for newborn blood spot screening, publishes dataÂ
Dr Heather PayneÂ
- Trustee of Representative Body of the Church in Wales (since January 2025). Elected lay member, unpaidÂ
Liz RobinsonÂ
- ²Ô´Ç²Ô±ðÌý
Dr Graham ShortlandÂ
- interests listed on  UK NSC r±ð²µ¾±²õ³Ù±ð°ùÌý
Susan SpillaneÂ
- ²Ô´Ç²Ô±ðÌý
Sarah StevensÂ
- ²Ô´Ç²Ô±ðÌý
Sian Taylor-PhillipsÂ
- interests listed on UK NSCÌý°ù±ð²µ¾±²õ³Ù±ð°ùÌý
Dr Ellen ThomasÂ
- works for Genomics England and is the Chief Investigator of the Generation StudyÂ
Prof Rachael WoodÂ
- interests listed on FMCH r±ð²µ¾±²õ³Ù±ð°ù